Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Prof. Dr. Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Federal University of Jataí | Brazil

Prof. Dr. Eduardo Vignoto Fernandes, is a distinguished researcher in immunometabolism, human physiology, and applied health sciences, recognized for his multidisciplinary contributions integrating experimental pathology, human anatomy, and exercise science. With 28 Scopus-indexed publications, 119 citations, and an h-index of 5, his research advances understanding of metabolic, genetic, and physiological adaptations in healthy individuals and those with clinical or lifestyle-related conditions, including people living with HIV/AIDS. Fernandes has produced influential studies covering immunometabolism responses, exercise physiology, body composition, sports nutrition, metabolic syndrome, cancer immunopathology, and antiretroviral therapy effectiveness. His scientific output includes peer-reviewed articles, systematic reviews, and collaborative investigations published in respected journals such as Metabolites, Geriatrics, Sports, Current HIV Research, Molecular Biology Reports, and Discover Public Health. Fernandes leads and collaborates on research projects exploring exercise prescription, photo biomodulation, osteopathic interventions, muscle damage biomarkers, and functional health indicators such as handgrip strength. His expertise also extends to educational research on human anatomy, including remote versus in-person instruction and academic performance in health-science students. Through public health outreach initiatives, he contributes to community wellness by developing structured exercise programs and participating in One Health–aligned interdisciplinary actions. Supported by competitive funding from major Brazilian agencies, he conducts R&D focused on immunometabolism health, functional performance, and applied health interventions. His growing citation base, broad research themes, and sustained collaborations underscore his scientific relevance and expanding impact across exercise science, pathology, and applied health research.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

1. De Rossi, T., Lozovoy, M. A. B., da Silva, R. V., Fernandes, E. V., Geraldino, T. H., & others. (2011). Interações entre Candida albicans e hospedeiro. Semina: Ciências Biológicas e da Saúde, 32(1), 15–28.

2. Weber, M. G., Dias, S. S., de Angelis, T. R., Fernandes, E. V., Bernardes, A. G., & others. (2021). The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: A systematic review and meta-analysis. Amino Acids, 53(11), 1663–1678.

3. Romanin, P., Palermo, R. L., Cavalini, J. F., Favaro, L. S., De Paula-Petroli, S. B., Fernandes, E. V., & others. (2019). Multidrug- and extensively drug-resistant Acinetobacter baumannii in a tertiary hospital from Brazil: The importance of carbapenemase encoding genes and related resistance mechanisms. Microbial Drug Resistance, 25(9), 1365–1373.

4. Khan, S. A., Venancio, E. J., Ono, M. A., Fernandes, E. V., Hirooka, E. Y., Shimizu, C. F., & others. (2019). Effects of subcutaneous ochratoxin-A exposure on immune system of broiler chicks. Toxins, 11(5), 264.

5. Vitorino, R. W. S., Fornaziero, C. C., & Fernandes, E. V. (2020). Evaluation of performance and perception of learning in teaching human anatomy: Traditional method vs constructivist method. International Journal of Morphology, 38(1), 74–77.

Hiba Muhammed | Bioelectronics and Biomaterials | Best Researcher Award

Published on by Forensic Scientist

Ms. Hiba Muhammed | Bioelectronics and Biomaterials | Best Researcher Award

University of Calicut | India

Ms. Hiba Muhammed is an emerging researcher in pharmacology and biomedical sciences with interdisciplinary expertise bridging pharmacology, chemistry, and nanotechnology. Her research contributions encompass nanomaterial synthesis, drug design, neuropharmacology, and biomedical applications of hybrid composites. She has co-authored publications in reputed international journals such as Physica B: Condensed Matter and Journal of the Indian Chemical Society, where her work explored nanocurcumin–titanium dioxide bio-nanocomposites and multifunctional chitosan–chloro-aspirin materials for biomedical and energy applications. She has also contributed a book chapter on the therapeutic potential of carbon nanotubes in managing chronic obstructive pulmonary disease. Her academic research projects include investigations into neuroprotective agents and green-synthesized zinc oxide nanoparticles, highlighting her focus on translational pharmacology and biocompatible nanomaterials. She has been recognized with multiple academic excellence awards and holds a university rank in pharmacology. With active participation in national and international conferences, poster presentations, and workshops on biostatistics, pharmacovigilance, and computational drug discovery, Ms. Hiba Muhammed demonstrates a strong commitment to advancing experimental pharmacology and nano biomedicine. Her works have earned citations indexed in Scopus, reflecting growing recognition in the scientific community.

Profile: Scopus

Featured Publications

• Anju, P., Muhammed, H., Kantholi, A., Bahuleyan, B., & Ramesan, M. T. (2025). Synthesis of nanocurcumin conjugated titanium dioxide bio-nanocomposites for enhanced optical, thermal, electrical, and antibacterial applications. Physica B: Condensed Matter, 711, 417269. https://doi.org/10.1016/j.physb.2025.417269

• Muhammed, H., Faheema, S., Thayyil, M. S., Udayan, G., & Ramesan, M. T. (2025). Multifunctional chitosan/chloro-aspirin composites for energy storage and biomedical applications. Journal of the Indian Chemical Society, 102(8), 101866. https://doi.org/10.1016/j.jics.2025.101866

Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Published on by Forensic Scientist

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.